Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_assertion description "[Despite the evidence of early insulin treatment lowering macrovascular (coronary artery disease, peripheral arterial disease and stroke) and microvascular (diabetic nephropathy, neuropathy and retinopathy) complications of T2DM, controversy exists among physicians on how to initiate and intensify insulin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_assertion evidence source_evidence_literature NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_assertion SIO_000772 23584214 NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_assertion wasDerivedFrom befree-20150227 NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_assertion wasGeneratedBy ECO_0000203 NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.
- befree-20150227 importedOn "2015-02-27" NP513081.RA0PtNmP1d-m2CrT52PtjKGr3Gp-cbJXQbQWJvgoRra2k130_provenance.